A hepatitis B hold lifted and drug tabled; Ultomiris' accelerated approval
Plus news about Biohaven, Arcus Biosciences and a Boehringer Ingelheim and Microsoft collaboration. Hold on Arbutus drug lifted: It’s been a long, tough road for Arbutus Biopharma. The company has
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.